Pfizer, a company in the Pharmaceuticals industry, reported revenue of ₹727 crore and net profit of ₹313 crore for the September 2026 quarter.
Pfizer (NSE: PFIZER) closed at ₹3,856.00 on 20 Nov 2026, down 23.3% over the past year. Its market capitalisation is ₹17,640 crore and it trades at 22.2 times earnings.
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.